It’s that season again and allergy sufferers are indeed, suffering.  With your whole world in full bloom, I bet  these scenarios ring a bell...

A three-year study of 50 patients aged between 13 and 30, who were treated for keratoconus at IMO in Barcelona with the technique known as crosslinking, has confirmed the effectiveness of a treatment that slows down the progress of a disease that is the main reason for corneal transplantation in young people.

Keratoconus
[ k er-u h-toh-k oh-nuh s]

Keratoconus or “KC” is a non-inflammatory eye condition in which the normally round dome-shaped cornea progressively thins causing a cone-like bulge to develop. This results in significant visual impairment.